DEF: electroCore, Inc. Seeks Shareholder Approval for Board Declassification and Key Governance Updates

electroCore, Inc. has issued its proxy statement for the 2025 Annual Meeting of Stockholders, seeking approval for significant corporate governance changes including board declassification, director elections, auditor ratification, and executive compensation.

Summary

• The Annual Meeting of Stockholders will be held virtually on Tuesday, September 2, 2025, at 9:00 a.m. Eastern Time.
• The record date for voting is July 7, 2025, with 7,466,425 shares of common stock outstanding and entitled to vote.
• Proposal 1 seeks to approve amendments to the Company's Certificate of Incorporation to declassify the Board, phasing in annual election of all directors starting at the 2027 Annual Meeting of Stockholders. This proposal requires the affirmative vote of at least two-thirds of the outstanding shares.
• Proposal 2 involves the election of three Class I directors (Daniel S. Goldberger, Julie A. Goldstein, and Patricia Wilber) for a three-year term (if declassification is not approved) or a two-year term (if declassification is approved).
• Proposal 3 requests ratification of CBIZ CPAs P.C. (f/k/a Marcum LLP) as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
• Proposal 4 is a non-binding advisory vote to approve the compensation of the named executive officers.
• The Board unanimously recommends voting FOR all four proposals.
• The Company reported a net loss of $(11,886,000) for fiscal year 2024, an improvement from $(18,834,000) in 2023 and $(22,162,000) in 2022.
• Total Shareholder Return (TSR) increased by 85% during the three years ended December 31, 2024.

Sentiment

Score: 7

Explanation: The company is proactively addressing corporate governance by proposing board declassification, which aligns with shareholder interests and modern trends. Financial performance shows a positive trend with a significant reduction in net loss and strong Total Shareholder Return, although the company remains unprofitable. A recent capital raise indicates continued funding for operations.

Positives

• The Board is proposing to declassify its structure, aligning with institutional investor sentiment and modern corporate governance trends, with 98.16% of shares having voted in favor of declassification at the 2021 annual meeting.
• Net loss significantly improved by 46% from $(22,162,000) in 2022 to $(11,886,000) in 2024.
• Total Shareholder Return (TSR) increased by 85% during the three years ended December 31, 2024.
• A previously reported material weakness in internal control over financial reporting related to vendor management has been remediated.
• The Company adopted a written compensation recovery (clawback) policy in accordance with Nasdaq rules.
• New corporate governance policies, including a Related Party Transaction Policy and an Insider Trading Policy prohibiting hedging, have been adopted.
• The Board maintains an independent Chairman, separating the roles of Board Chairman and Chief Executive Officer, which is believed to enhance Board independence and oversight.

Negatives

• The Company continues to operate at a net loss, reporting $(11,886,000) for fiscal year 2024.
• A material weakness in internal control over financial reporting due to a deficiency in controls over vendor management was identified as of September 30, 2023, though it has since been remediated.

Risks

• Forward-looking statements rely on assumptions and involve risks and uncertainties, many of which are beyond the Company's control, including factors detailed in Part I, Item 1A. Risk Factors and other sections of the most recent Annual Report on Form 10-K and subsequent SEC filings.
• Actual outcomes may vary materially from those indicated in forward-looking statements if underlying assumptions prove incorrect or risks materialize.

Future Outlook

The Board intends to file a Certificate of Amendment with the Delaware Secretary of State as soon as practicable after the declassification proposal is approved, followed by conforming changes to the Company's bylaws. Annual election of all directors will be phased in gradually, beginning at the 2027 Annual Meeting of Stockholders. Final voting results will be published in a current report on Form 8-K within four business days after the Annual Meeting. The CEO's 2024 target discretionary bonus includes an additional 5% based on the Company achieving cash flow breakeven in the second half of 2025.

Management Comments

• "The Board has believed that this classified structure promotes continuity and stability of strategy, oversight and policies, provides negotiating leverage to the Board in a potential takeover situation and facilitates the ability of the Board to focus on creating long-term stockholder value."
• "The Board (including the members of the nominating and governance committee) has continued to consider sentiment, particularly in the institutional investor community, in favor of annual elections."
• "The Board is also cognizant that many other companies who recently went public have eliminated their classified board structures in recent years."
• "The Board believes that separation of the positions of Board Chairman and Chief Executive Officer reinforces the independence of the Board in its oversight of the business and affairs of us."
• "Our compensation philosophy is centered around two key tenets: (1) building long-term value for our stockholders, and (2) driving employee engagement."
• "Our equity-based incentive awards are designed to align our interests with those of our employees and consultants, including our executive officers."

Industry Context

The Company is proposing to declassify its board, acknowledging a trend among institutional investors and recently public companies to move towards annual director elections, indicating a shift towards more modern corporate governance practices prevalent in the industry. The Company operates within the medical device industry, as evidenced by the professional backgrounds of its executive officers and directors.

Comparison to Industry Standards

• The Board's proposal to declassify its structure aligns with a broader trend among recently public companies that have eliminated classified board structures, reflecting a move towards governance practices favored by institutional investors.
• Executive compensation is determined by considering compensation for comparable positions in the market, utilizing identified industry comparables and industry/size-specific survey data, as well as analyses of executive and director compensation paid at other companies considered comparable to the Company, though specific comparable companies are not named in the document.

Management Changes

Corporate Governance

Related Party Transactions

• Consulting Agreement with Joseph P. Errico (former director), effective May 22, 2023, for Science and Strategic Advisor services, with Mr. Errico receiving $97,315 in 2024.
• An unrestricted educational grant of $120,000 was agreed to be provided to the Vagus Nerve Society in 2024, an organization co-founded by an executive of the Company, with $82,500 provided in 2024.
• A private placement on June 5, 2024, involved the sale of common stock, pre-funded warrants, and warrants to several directors and a related entity, Happy Holstein Management, LLC (managed by the spouse of a former director).
• A consulting agreement dated July 11, 2024, with F. Peter Cuneo (a board member) to provide consulting and advisory services to the CEO after his Board service ends, including hourly/per diem fees and a grant of 50,000 stock options.
• A consulting agreement dated October 4, 2024, with Brian M. Posner (a former executive) to provide financial and accounting consulting services on an hourly basis for 12 months after his retirement.

Stakeholder Impact

• **Shareholders**: Potential for increased accountability and responsiveness from the Board due to proposed declassification. Opportunity to vote on key governance matters and executive compensation. Benefit from improved Total Shareholder Return. Potential for dilution from the recent private placement.
• **Employees**: Participation in employee benefit plans, including medical, dental, and 401(k). Executive compensation philosophy aims to attract and engage high-caliber talent and align interests with long-term value creation.
• **Management**: Compensation structure includes base salary, discretionary bonuses, and long-term equity incentives. Executive severance policy provides benefits upon certain terminations. Changes in roles for CFO position.
• **Auditors**: CBIZ CPAs has been selected as the new independent registered public accounting firm, replacing Marcum LLP due to an acquisition, ensuring continuity of audit services.

Next Steps

• Hold the Annual Meeting of Stockholders on September 2, 2025, to vote on the proposed matters.
• If Proposal 1 (Board declassification) is approved, file a Certificate of Amendment with the Delaware Secretary of State as soon as practicable and make required conforming changes to the Company's bylaws.
• Publish final voting results in a current report on Form 8-K within four business days after the Annual Meeting.
• Phase in the annual election of all directors beginning at the 2027 Annual Meeting of Stockholders.
• Consider stockholder proposals and director nominations for the 2026 Annual Meeting, adhering to specified deadlines.

Key Dates

Recommendation

Keywords

electroCore, Proxy Statement, Corporate Governance, Board Declassification, Director Election, Executive Compensation, Auditor Ratification, Shareholder Meeting, Financial Performance, Risk Management, Nasdaq, Medical Device